B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · see citing works

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works

N aturally A rising CD4+R egulatory T C ells for I mmunologic S elf -T olerance and N egative C ontrol of I mmune R esponses

Sakaguchi, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,293 · see citing works

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,204 · see citing works

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496 · see citing works

Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice

Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868 · see citing works

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968 · see citing works

Expression of Programmed Death 1 Ligands by Murine T Cells and APC

Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 950 · see citing works

The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses

Carreno, B. M., & Collins, M. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 895 · see citing works

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

Thompson, R. H., Kuntz, S. M., Leibovich, B. C., Dong, H., Lohse, C. M., Webster, W. S., Sengupta, S., Frank, I., Parker, A. S., Zincke, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4303 · Cited by 869 · see citing works

Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Dong, H., Strome, S. E., Salomão, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm0902-1039c · Cited by 545 · see citing works

The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function

Coyle, A. J., & Gutierrez-Ramos, J.-C. (2001) · Nature Immunology · doi:10.1038/85251 · Cited by 412 · see citing works

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3 + CD4 + regulatory T cells

Wang, L., Pino‐Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H., & Noelle, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710441105 · Cited by 390 · see citing works

Expression of the B7 - related molecule B7 - H1 by glioma cells: a potential mechanism of immune paralysis

Wintterle, Schreiner, Mitsdoerffer, Schneider, Chen, Meyermann, Weller, M., & Wiendl (2003) · 中国神经肿瘤杂志 · Cited by 366 · see citing works

B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy

Selenko-Gebauer, N., Majdic, O., Szekeres, A., Höfler, G., Guthann, E., Korthäuer, U., Zlabinger, G. J., Steinberger, P., Pickl, W. F., Stockinger, H. S. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3637 · Cited by 261 · see citing works

Dendritic Cells Derived In Vitro From Acute Myelogenous Leukemia Cells Stimulate Autologous, Antileukemic T-Cell Responses

Choudhury, A., Liang, J. C., Thomas, E. K., Flores‐Romo, L., Xie, Q., Agusala, K., Sutaria, S. S., Sinha, I., Champlin, R. E., & Claxton, D. F. (1999) · Blood · doi:10.1182/blood.v93.3.780 · Cited by 239 · see citing works

In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis

Saudemont, A., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-01-0064 · Cited by 178 · see citing works

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161 · see citing works

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells

Saudemont, A., Jouy, N., Hétuin, D., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-09-3458 · Cited by 131 · see citing works

CD34+ Acute Myeloid and Lymphoid Leukemic Blasts Can Be Induced to Differentiate Into Dendritic Cells

Cignetti, A., Bryant, E., Allione, B., Vitale, A., Foà, R., & Cheever, M. A. (1999) · Blood · doi:10.1182/blood.v94.6.2048 · Cited by 130 · see citing works

Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications inDe novoAcute Myeloid Leukemia

Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S.-D., Dong, H., Chen, L., & Ogata, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2672 · Cited by 119 · see citing works

Expression of the Programmed Death Ligand 1, B7-H1, on Gastric Epithelial Cells afterHelicobacter pyloriExposure Promotes Development of CD4+CD25+FoxP3+Regulatory T Cells

Beswick, E. J., Pinchuk, I. V., Das, S., Powell, D. W., & Reyes, V. E. (2007) · Infection and Immunity · doi:10.1128/iai.00553-07 · Cited by 110 · see citing works

Stimulation of autologous proliferative and cytotoxic T-cell responses by “leukemic dendritic cells” derived from blast cells in acute myeloid leukemia

Harrison, B. D., Adams, J. A., Briggs, M., Brereton, M. L., & Yin, J. A. L. (2001) · Blood · doi:10.1182/blood.v97.9.2764 · Cited by 102 · see citing works

Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.

Spisek, R., Chevallier, P., Morineau, N., Milpied, N. J., Avet‐Loiseau, H., Harousseau, J., Méflah, K., & Grégoire, M. (2002) · PubMed · Cited by 94 · see citing works

Leukemia-Derived Immature Dendritic Cells Differentiate into Functionally Competent Mature Dendritic Cells That Efficiently Stimulate T Cell Responses

Cignetti, A., Vallario, A., Roato, I., Circosta, P., Allione, B., Casorzo, L., Ghia, P., & Caligaris‐Cappio, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2855 · Cited by 56 · see citing works

Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.

Sasatomi, E., Finkelstein, S. D., Woods, J., Bakker, A., Swalsky, P. A., Luketich, J. D., Fernando, H. C., & Yousem, S. A. (2002) · PubMed · Cited by 53 · see citing works

The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans

Salih, H. R., Wintterle, S., Krusch, M., Kroner, A., Huang, Y.-H., Chen, L., & Wiendl, H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.006 · Cited by 49 · see citing works

Induction of BCR-ABL–specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells

Zeng, Y., Graner, M. W., Thompson, S., Marron, M., & Katsanis, E. (2004) · Blood · doi:10.1182/blood-2004-05-1915 · Cited by 41 · see citing works

Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts

Mohty, M., Olive, D., & Gaugler, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402710 · Cited by 39 · see citing works

Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy

Sempowski, G. D., Rhein, M. E., Scearce, R. M., & Haynes, B. F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11 · Cited by 38 · see citing works

Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts

Gong, J., Koido, S., Kato, Y., Tanaka, Y., Chen, D., Jonas, A. K., Galinsky, I. A., DeAngelo, D. J., Avigan, D., Kufe, D. W., et al. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.03.018 · Cited by 37 · see citing works

Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation

Blair, A., Goulden, N., Libri, N. A., Oakhill, A., & Pamphilon, D. (2005) · Blood Reviews · doi:10.1016/j.blre.2004.09.002 · Cited by 33 · see citing works

Intratumoral Injection of Dendritic Cells Transduced by an SV40-Based Vector Expressing Interleukin-15 Induces Curative Immunity Mediated by CD8+ T Lymphocytes and NK Cells

Vera, M., Razquin, N., Prìeto, J., Melero, I., Fortes, P., & González‐Aseguinolaza, G. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.030 · Cited by 31 · see citing works

Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1

Roddie, P. H., Horton, Y. M., & Turner, M. L. (2002) · Leukemia · doi:10.1038/sj.leu.2402335 · Cited by 31 · see citing works

Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts

Schui, D. K., Singh, L., Schneider, B., Knau, A., Hoelzer, D. F., & Weidmann, E. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00141-2 · Cited by 24 · see citing works

Gene co-expression analysis for functional classification and gene–disease predictions

van Dam, S., Võsa, U., van der Graaf, A., Franke, L., & de Magalhães, J. P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw139 · Cited by 1,086 · see citing works

Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage

Zhu, H., Wang, Z., Yu, J., Yang, X., He, F., Liu, Z., Che, F., Chen, X., Ren, H., Hong, M., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.03.003 · Cited by 319 · see citing works

Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.

Talukdar, S., Bhoopathi, P., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. (2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.12.002 · Cited by 141 · see citing works

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

Anguille, S., Smits, E., Bryant, C. E., Acker, H. H. V., Goossens, H., Lion, E., Fromm, P. D., Hart, D. N. J., Tendeloo, V. F. V., & Berneman, Z. N. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009456 · Cited by 152 · see citing works

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape

Hsieh, Y.-C., Kirschner, K., & Copland, M. (2021) · Leukemia · doi:10.1038/s41375-021-01238-w · Cited by 113 · see citing works

The immunoinhibitory B7-H1 molecule as a potential target in cancer

Dermime, S., & Afreen, S. (2014) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2013.09.005 · Cited by 100 · see citing works

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Versteven, M., den Bergh, J. M. J. V., Marcq, E., Smits, E., Tendeloo, V. F. V., Hobo, W. A., & Lion, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00394 · Cited by 97 · see citing works

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

Yang, X., Ma, L., Zhang, X., Huang, L., & Wei, J. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00263-4 · Cited by 98 · see citing works

The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance

Janikashvili, N., Bonnotte, B., Katsanis, E., & Larmonier, N. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/430394 · Cited by 95 · see citing works

Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients

Govindaraj, C., Tan, P. T., Walker, P., Wei, A. H., Spencer, A. G., & Plebanski, M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1576 · Cited by 86 · see citing works

Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas

Chen, J., Li, G., Meng, H., Fan, Y., Song, Y., Wang, S., Zhu, F., Guo, C. H., Zhang, L., & Shi, Y. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1094-3 · Cited by 85 · see citing works

Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80

Haile, S. T., Bosch, J. J., Agu, N., Zeender, A. M., Somasundaram, P., Srivastava, M. K., Britting, S., Wolf, J. B., Ksander, B. R., & Ostrand‐Rosenberg, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003682 · Cited by 84 · see citing works

Immunotherapy prospects for acute myeloid leukaemia

Barrett, A. J., & Blanc, K. L. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04197.x · Cited by 82 · see citing works

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

van Gulijk, M., Dammeijer, F. F., Aerts, J. G. J. V., & Vroman, H. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02759 · Cited by 79 · see citing works

Clinical opportunities and challenges in targeting tumour dormancy

Hensel, J. A., Flaig, T. W., & Theodorescu, D. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.207 · Cited by 68 · see citing works

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

Belderbos, R. A., Aerts, J. G. J. V., & Vroman, H. H. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.03.007 · Cited by 67 · see citing works

Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway

Xu, Y., Mou, J., Wang, Y., Zhou, W., Rao, Q., Xing, H., Tian, Z., Tang, K., Wang, M., & Wang, J. (2021) · Leukemia · doi:10.1038/s41375-021-01375-2 · Cited by 63 · see citing works

Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α–TNF Receptor-2 Pathway

Wang, M., Zhang, C., Tian, T., Zhang, T., Wang, R., Han, F., Zhong, C., Hua, M., & Ma, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01274 · Cited by 61 · see citing works

Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis

Karimizadeh, E., Sharifi‐Zarchi, A., Nikaein, H., Salehi, S., Salamatian, B., Elmi, N., Gharibdoost, F., & Mahmoudi, M. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0632-2 · Cited by 61 · see citing works

Myeloid leukemia cells with a B7‐2+ subpopulation provoke Th‐cell responses and become immuno‐suppressive through the modulation of B7 ligands

Dölen, Y., & Esendağlı, G. (2012) · European Journal of Immunology · doi:10.1002/eji.201242814 · Cited by 48 · see citing works

Lenalidomide‐based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients

Govindaraj, C., Madondo, M., Kong, Y., Tan, P. T., Wei, A. H., & Plebanski, M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23746 · Cited by 47 · see citing works

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias

Schürch, C. M., Riether, C., & Ochsenbein, A. F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00496 · Cited by 42 · see citing works

An OMV‐Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy

Lu, Y., Ma, N., Cheng, K., Liu, G., Liang, J., Chen, X., Li, D., Cao, C., Gao, X., Chen, L., et al. (2025) · Advanced Materials · doi:10.1002/adma.202413392 · Cited by 38 · see citing works

Biology and Clinical Observations of Regulatory T Cells in Cancer Immunology

Teng, M. W. L., Ritchie, D. S., Neeson, P. J., & Smyth, M. J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_50 · Cited by 38 · see citing works

A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers

Dehbashi, M., Hojati, Z., Motovali-Bashi, M., Ganjalikhany, M. R., Cho, W. C. S., Shimosaka, A., Navabi, P., & Ganjalıkhani-Hakemi, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649710 · Cited by 31 · see citing works

Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside

Ghorbaninezhad, F., Asadzadeh, Z., Masoumi, J., Mokhtarzadeh, A., Kazemi, T., Maleki, L. A., Shotorbani, S. S., Shadbad, M. A., Baghbanzadeh, A., Hemmat, N., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120466 · Cited by 32 · see citing works

ecancermedicalscience

Gelao, L., Criscitiello, C., Fumagalli, L. A. M., Locatelli, M., Manunta, S., Esposito, A., Minchella, I., Goldhirsch, A., & Curigliano, G. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2013.320 · Cited by 30 · see citing works

Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer

Petersen, S. H., Kua, L., Nakajima, S., Yong, W. P., & Kono, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-91603-7 · Cited by 25 · see citing works

Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review

Kaboli, P. J., Zhang, L., Xiang, S., Shen, J., Li, M., Zhao, Y., Wu, X., Zhao, Q., Zhang, H., Lin, L., et al. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191004164041 · Cited by 24 · see citing works

Current Strategies in Immunotherapy for Acute Myeloid Leukemia

Lichtenegger, F. S., Schnorfeil, F. M., Hiddemann, W., & Subklewe, M. S. (2012) · Immunotherapy · doi:10.2217/imt.12.145 · Cited by 22 · see citing works

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

Versteven, M., den Bergh, J. M. J. V., Broos, K., Fujiki, F., Campillo-Davó, D., Reu, H. D., Morimoto, S., Lecocq, Q., Keyaerts, M., Berneman, Z. N., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25591 · Cited by 22 · see citing works

Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

O’Brien, L., Guillerey, C., & Radford, K. J. (2019) · Cancers · doi:10.3390/cancers11060875 · Cited by 21 · see citing works

The B7 Homologues and their Receptors in Hematologic Malignancies

Wilcox, R. A., Ansell, S. M., Lim, M. S., Zou, W., & Chen, L. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01766.x · Cited by 20 · see citing works

Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target

Liu, M., Yang, M., Qi, Y., Ma, Y., Guo, Q., Guo, L., Liu, C., Liu, W., Xiao, L., & Yang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1627161 · Cited by 19 · see citing works

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia

Jimbu, L., Mesaros, O., Neaga, A., Nanut, A. M., Tomuleasa, C., Dima, D. M., Bocșan, I. C., & Zdrenghea, M. (2021) · Pharmaceuticals · doi:10.3390/ph14111105 · Cited by 18 · see citing works

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications

Angstadt, S. M., Zhu, Q., Jaffee, E. M., Robinson, D. N., & Anders, R. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809179 · Cited by 14 · see citing works

Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation

Chai, J. N., Choudhuri, J., Wang, Q., Fang, Y., Shi, Y., Kamel, J. M., Shah, N. N., Sica, R. A., Kornblum, N. S., Konopleva, M., et al. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2232494 · Cited by 2 · see citing works

USP13 promotes acute myeloid leukemia cell proliferation and autophagy by promoting ATG5

Yuan, Y., Xue, M., Zhou, F., & Gu, L. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102494 · Cited by 1 · see citing works

Modulation of dendritic cells and autoimmunity by apoptotic and necrotic cells

Miller, J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1 · see citing works

Etude de la réponse immunitaire T au cours de l'artérite à cellules géantes (Maladie de Horton)

Samson, M. (2014) · doi:10.70675/2a8ec4b3zb64az4800z9403z8e77d536e088

A possible IDO1- TSP1 role in breast cancer dormancy

Lopes-Bastos, B. (2017) · ORCA Online Research @Cardiff (Cardiff University)

Computational study for suppression of CD25/IL-2 interaction

Dehbashi, M., Hojati, Z., Motovali-Bashi, M., Ganjalıkhani-Hakemi, M., Shimosaka, A., & Cho, W. C. S. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0326

Dissecting big RNA-Seq cancer data using machine learning to find disease-associated genes and the causal mechanism

Sarmah, D. T., Kumar, S., Chatterjee, S., & Bairagi, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85713-0.00015-3

Activation of PD‐1/PD‐L1 Pathway by Total Glucosides of Peony Induces Regulatory T‐Cells to Ameliorate Myocardial Ischemia‐Reperfusion Injury

An, R., Li, Q., Sheng, B., Ou, Y., Chen, L., Shen, Y., Yuan, Y., & Pang, L. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/8112703

Effects of B7-H1 molecule blockade on tumor-infiltrating dendritic cell-mediated T-cell function

Chen, Y., Xiaohua, L., Ruofan, H., & Zhou, X. (2009) · 癌症：英文版

The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans

Salih, H. R., Wintterle, S., Krusch, M., Kroner, A., Huang, Y.-H., Chen, L., & Wiendl, H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.006 · Cited by 49 · see citing works

B7-H1 negatively regulates IL-12 production by dendritic cells (165.10)

Gibbons, R., Liu, X., & Dong, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.188.supp.165.10

The Role of Leukemia Derived B7-H1 in Tumor-T-Cell Interactions in Humans.

Krusch, M., Wintterle, S., Chen, L., Kanz, L., Wiendl, H., & Salih, H. R. (2005) · Blood · doi:10.1182/blood.v106.11.4566.4566

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works